Working with the US Food and Drug Administration: Progress and timelines in understanding and treating patients with eosinophilic esophagitis

Journal of Allergy and Clinical Immunology

Volumn 130, Issue 3, 2012, Pages 617-619

  Rothenberg, Marc E ^a   Aceves, Seema ^b   Bonis, Peter A ^c   Collins, Margaret H ^a   Gonsalves, Nirmala ^d   Gupta, Sandeep K ^e   Hirano, Ikuo ^d   Liacouras, Chris A ^f   Putnam, Phil E ^a   Spergel, Jonathan M ^f   Straumann, Alex ^g   Wershil, Barry K ^d   Furuta, Glenn T ^h  

^a UNIVERSITY OF CINCINNATI   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c TUFTS UNIVERSITY   (United States)

^d NORTHWESTERN UNIVERSITY   (United States)

^e INDIANA UNIVERSITY   (United States)

^f UNIVERSITY OF PENNSYLVANIA   (United States)

^g UNIVERSITY OF BASEL   (Switzerland)

^h UNIVERSITY OF COLORADO   (United States)

Author keywords

Eosinophils; esophagitis; symptoms; therapy

Indexed keywords

CORTICOSTEROID; MEPOLIZUMAB; RESLIZUMAB;

CORTICOSTEROID THERAPY; DISEASE COURSE; DISEASE REGISTRY; DYSPNEA; EOSINOPHILIC ESOPHAGITIS; HEALTH CARE ORGANIZATION; HEREDITY; ICD-9; MASTOCYTOSIS; OUTCOME ASSESSMENT; PATHOGENESIS; PRIORITY JOURNAL; PUBLICATION; REVIEW;

EID: 84865681018     PISSN: 00916749     EISSN: 10976825     Source Type: Journal    
DOI: 10.1016/j.jaci.2012.06.051     Document Type: Editorial

References (10)

1. R. Fiorentino, G. Liu, A. Pariser, and A. Mulberg Cross-sector sponsorship of research in eosinophilic esophagitis: a collaborative model for rational drug development in rare disease J Allergy Clin Immunol 130 2012 613 616
2. C.A. Liacouras, G.T. Furuta, I. Hirano, D. Atkins, S.E. Attwood, and P.A. Bonis Eosinophilic esophagitis: updated consensus recommendations for children and adults J Allergy Clin Immunol 128 1 2011 3 22.e6
3. D.L. Patrick, L.B. Burke, J.H. Powers, J.A. Scott, E.P. Rock, and S. Dawisha Patient-reported outcomes to support medical product labeling claims: FDA perspective Value Health 10 suppl 2 2007 S125 S137
4. M.R. Konikoff, R.J. Noel, C. Blanchard, C. Kirby, S.C. Jameson, and B.K. Buckmeier A randomized, double-blind, placebo-controlled trial of fluticasone propionate for pediatric eosinophilic esophagitis Gastroenterology 131 2006 1381 1391
5. J.D. Sherrill, and M.E. Rothenberg Genetic dissection of eosinophilic esophagitis provides insight into disease pathogenesis and treatment strategies J Allergy Clin Immunol 128 2011 23 32
6. R. Dohil, R. Newbury, L. Fox, J. Bastian, and S. Aceves Oral viscous budesonide is effective in children with eosinophilic esophagitis in a randomized, placebo-controlled trial Gastroenterology 139 2010 418 429
7. M.E. Wechsler, J.M. Kelley, I.O. Boyd, S. Dutile, G. Marigowda, and I. Kirsch Active albuterol or placebo, sham acupuncture, or no intervention in asthma N Engl J Med 365 2011 119 126
8. J.M. Valderas, A. Kotzeva, M. Espallargues, G. Guyatt, C.E. Ferrans, and M.Y. Halyard The impact of measuring patient-reported outcomes in clinical practice: a systematic review of the literature Qual Life Res 17 2008 179 193
9. A. Straumann, E. Safroneeva, and A.M. Schoepfer Placebo and other interventions in asthma N Engl J Med 365 2011 1446 1448
10. Sasinowski F. Quantum of effectiveness evidence in FDA's approval of orphan drugs. National Organization for Rare Disorders, 2011 Available at: Rarediseases.org. Accessed June 12, 2012.